FrancophonIA/ELRC3.0 huggingface dataset:
English: Please tell your doctor if you are suffering or have suffered from: - high blood pressure which is being controlled with medicines prescribed by your doctor; - sickle cell anaemia; - epileptic fits (seizures); - convulsions (fits or seizures); - liver disease; - significant lack of response to medicines used to treat anaemia; - an allergy to latex (the needle cap on the pre-filled syringe contains a derivative of latex); or - hepatitis C.
Spanish: Informe a su médico si usted padece o ha padecido: - tensión arterial alta que está siendo tratada con medicamentos recetados por su médico; - anemia de células falciformes; - ataques epilépticos (ataques); - convulsiones (espasmos y ataques); - enfermedad del hígado; - si no responde a medicamentos utilizados para tratar la anemia; - alergia al látex (el capuchón de la aguja de la jeringa precargada contiene un derivado del látex);
English: Do not remove the cap from the syringe until you are ready to inject.
Spanish: No quite el capuchón de la aguja hasta que esté preparado para la inyección.
English: Please tell your doctor if you are suffering or have suffered from: - high blood pressure which is being controlled with medicines prescribed by your doctor; - sickle cell anaemia; - epileptic fits (seizures); - convulsions (fits or seizures); - liver disease; - significant lack of response to medicines used to treat anaemia; - an allergy to latex (the needle cap on the pre-filled pen contains a derivative of latex); or - hepatitis C.
Spanish: Informe a su médico si usted padece o ha padecido: - tensión arterial alta que está siendo tratada con medicamentos recetados por su médico; - anemia de células falciformes; - ataques epilépticos (ataques); - convulsiones (espasmos y ataques); - enfermedad del hígado; - si no responde a medicamentos utilizados para tratar la anemia; - alergia al látex (el capuchón de la aguja de la pluma precargada contiene un derivado del látex);
English: If the increase in haemoglobin is inadequate (less than 1 g/dL (0.6 mmol/L) in four weeks) increase the dose by approximately 25%.
Spanish: Si el aumento de la hemoglobina fuera inadecuado (menos de 1 g/dl (0,6 mmol/l) en 4 semanas) la dosis se aumentará en aproximadamente un 25%.
English: For all adult and paediatric patients ≥ 1 year of age with chronic renal failure, Aranesp is given as a single injection by a healthcare professional, either under your skin (subcutaneous) or into a vein (intravenous).
Spanish: Para todos los pacientes adultos y pediátricos ≥ 1 año de edad con insuficiencia renal crónica, Aranesp se administra en una única inyección por un profesional sanitario debajo de la piel (subcutánea) o en una vena (intravenosa).
English: Oedemad
Spanish: Edemad
English: Aranesp is a clear, colourless or slightly pearly solution for injection in a pre-filled pen.
Spanish: Aranesp es una solución inyectable transparente, incolora o ligeramente opalescente, en pluma precargada.
English: Haemoglobin variability should be addressed through dose management, with consideration for the haemoglobin target range of 10 g/dL (6.2 mmol/L) to 12 g/dL (7.5 mmol/L).
Spanish: La variabilidad en los niveles de hemoglobina se debe controlar mediante el ajuste de la dosis con el objeto de mantener los valores de la hemoglobina dentro del intervalo entre 10 g/dl (6,2 mmol/l) y 12 g/dl (7,5 mmol/l).
English: Source: Includes 5 randomised, double-blind, active-controlled studies (970200, 970235, 980117, 980202, and
Spanish: Fuente: se incluyen cinco estudios aleatorizados, doble ciego y controlados con tratamiento activo (970200,
English: Amgen S.r.l Tel: +39 02 6241121
Spanish: Tel: +39 02 6241121
English: Do not use the pre-filled pen if the pre-filled pen has been dropped.
Spanish: No utilice la pluma precargada si se ha caído.
English: If the haemoglobin exceeds 12 g/dL (7.5 mmol/L), a dose reduction should be considered.
Spanish: Si la hemoglobina rebasa los 12 g/dl (7,5 mmol/l), se deberá evaluar la necesidad de reducir la dosis.
English: Aranesp 25 micrograms solution for injection in vial Each vial contains 25 micrograms of darbepoetin alfa in 1 mL (25 mcg/mL).
Spanish: Aranesp 25 microgramos solución inyectable en vial Cada vial contiene 25 microgramos de darbepoetina alfa en 1 ml (25 µg/ml).
English: c Thromboembolic events adverse reaction includes PT embolism arterial, thrombophlebitis, thrombosis, venous thrombosis limb.
Spanish: c Los eventos tromboembólicos incluyen los términos preferentes «embolia arterial», «tromboflebitis»,
English: Belly
Spanish: Muslo
English: Aranesp is available in packs of 1 or 4 pre-filled syringes.
Spanish: Aranesp está disponible en envases de 1 o 4 jeringas precargadas.
English: For all adult and paediatric patients ≥ 1 year of age with chronic renal failure, Aranesp is given as a single injection, either under your skin (subcutaneous) or into a vein (intravenous).
Spanish: Para todos los pacientes adultos y pediátricos ≥ 1 año de edad con insuficiencia renal crónica, Aranesp se administra en una única inyección, debajo de la piel (subcutánea) o en una vena (intravenosa).
English: The frequency is estimated from clinical trial data as uncommon.
Spanish: La frecuencia se estimó como poco frecuente a partir de los datos del ensayo clínico.
English: Do not use this medicine if you notice the pre-filled syringe contents are cloudy or there are particles in it.
Spanish: No utilice este medicamento si observa que el contenido de la jeringa precargada está turbio o contiene partículas.
English: Aranesp 25 micrograms solution for injection in vial.
Spanish: Aranesp 25 microgramos solución inyectable en vial.
English: Aranesp is a clear, colourless or slightly pearly solution for injection in a pre-filled syringe.
Spanish: Aranesp es una solución inyectable transparente, incolora o ligeramente opalescente, en jeringa precargada.
English: 1 single use pre-filled pen
Spanish: 1 pluma precargada monodosis
English: If the rise in haemoglobin is greater than 2 g/dL (1.25 mmol/L) in 4 weeks, the dose should be reduced by 25 to 50%.
Spanish: Si el incremento de hemoglobina es mayor de 2 g/dl (1,25 mmol/l) en un periodo de 4 semanas, se debe reducir la dosis entre el 25 y el 50%.
English: Do not use this medicine if you notice the pre-filled pen contents are cloudy or there are particles in it.
Spanish: No utilice este medicamento si observa que el contenido de la pluma precargada está turbio o contiene partículas.
English: Do not store the pre-filled pen in extreme heat or cold. For example, avoid storing in your car glove box or boot.
Spanish: No mantenga la pluma precargada en condiciones extremas de frío o calor.
English: Aranesp 10, 15, 20, 30, 40, 50, 60, 80, 100, 130, 150, 300, 500 micrograms solution for injection in pre-filled pen
Spanish: Aranesp 10, 15, 20, 30, 40, 50, 60, 80, 100, 130, 150, 300, 500 microgramos solución inyectable en pluma precargada
English: • Serious skin rashes including Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported in association with epoetin treatment.
Spanish: • Erupciones cutáneas graves, incluyendo el síndrome de Stevens-Johnson (SSJ) y necrólisis epidérmica tóxica (NET), han sido notificadas asociadas al tratamiento con epoetinas.
English: You could have serious problems if you receive more Aranesp than you need, such as very high blood pressure.
Spanish: Puede tener problemas graves si se administra más Aranesp del que debiera, como la tensión arterial muy alta. Contacte con su médico o farmacéutico si esto ocurriera.
English: • Upper part of your thigh
Spanish: • La parte superior del muslo
English: Keep the vial in the outer carton in order to protect from light.
Spanish: Conservar el vial dentro del embalaje exterior para protegerlo de la luz.
English: The initial weekly paediatric dose of Aranesp (mcg/week) can be determined by dividing the total weekly dose of r-HuEPO (IU/week) by 240.
Spanish: La dosis pediátrica semanal inicial de Aranesp (µg/semana) puede calcularse dividiendo entre 240 la dosis semanal total de r-HuEPO (IU/semana).
English: Aranesp 10, 15, 20, 30, 40, 50, 60, 80, 100, 130, 150, 300, 500 micrograms solution for injection in pre-filled syringe
Spanish: Aranesp 10, 15, 20, 30, 40, 50, 60, 80, 100, 130, 150, 300, 500 microgramos solución inyectable en jeringa precargada
English: Do not use this medicine after the expiry date which is stated on the carton and on the pre-filled pen label after EXP.
Spanish: No utilice este medicamento después de la fecha de caducidad que aparece en la caja y en la etiqueta de la pluma precargada después de “CAD” o “EXP”.
English: 1 single use pre-filled syringe.
Spanish: 1 jeringa precargada monodosis.
English: Expiry date
Spanish: FECHA DE CADUCIDAD
English: EXPIRY DATE
Spanish: Fecha de caducidad
English: The initial weekly dose of Aranesp (mcg/week) can be determined by dividing the total weekly dose of r-HuEPO (IU/week) by 200.
Spanish: La dosis semanal inicial de Aranesp (µg/semana) puede calcularse dividiendo entre 200 la dosis semanal total de r-HuEPO (IU/semana).
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING VIAL CARTON
Spanish: INFORMACIÓN QUE DEBE FIGURAR EN EL EMBALAJE EXTERIOR Y EL ACONDICIONAMIENTO PRIMARIO
English: Syringe label Used syringe barrel
Spanish: Alas Etiqueta de la jeringa Cuerpo de la jeringa
English: Keep the pre-filled pen in the outer carton in order to protect from light.
Spanish: Conservar la pluma precargada dentro del embalaje exterior para protegerla de la luz.
English: The median TTP based on IRCdetermined PD was 8.0 months in the epoetin alfa plus SOC group and 8.3 months in the SOC group (HR 1.033, 95% CI: 0.924, 1.156).
Spanish: La mediana de TP basada en la PE determinada por un comité de revisión independiente fue de 8,0 meses en el grupo de epoetina alfa más tratamiento habitual y de 8,3 meses en el grupo de solo tratamiento habitual (HR 1,033, IC del
English: Overall survival outcome in the trials could not be satisfactorily explained by differences in the incidence of thrombosis and related complications between those given recombinant human erythropoietin and those in the control group.
Spanish: Las diferencias observadas en la incidencia de trombosis y complicaciones relacionadas, entre los pacientes que recibieron eritropoyetina humana recombinante y los que formaban parte del grupo de control, no permiten explicar los resultados de supervivencia global observados en los ensayos.
English: 4 single use pre-filled syringes.
Spanish: 4 jeringas precargadas monodosis.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 130 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 130 µg inyectable
English: The pre-filled syringe contains either 10, 15, 20, 30, 40, 50, 60, 80, 100, 130, 150, 300 or 500 micrograms of darbepoetin alfa.
Spanish: Las plumas precargadas contienen 10, 15, 20, 30, 40, 50, 60, 80, 100, 130, 150, 300 o 500 microgramos de darbepoetina alfa.
English: INFORMATION IN BRAILLE Aranesp 130 syringe
Spanish: INFORMACIÓN EN BRAILLE Aranesp 130 jeringa
English: OR
Spanish: O
English: NAME OF THE MEDICINAL PRODUCT Aranesp 150 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 150 µg inyectable
English: NAME OF THE MEDICINAL PRODUCT Aranesp 20 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 20 µg inyectable
English: Pooled post-hoc analyses of clinical studies of ESAs have been performed in chronic renal failure patients (on dialysis, not on dialysis, in diabetic and non-diabetic patients).
Spanish: En pacientes con insuficiencia renal crónica (sometidos a diálisis, no sometidos a diálisis, pacientes diabéticos y pacientes no diabéticos) se han realizado análisis agrupados post-hoc de los estudios clínicos de los agentes estimulantes de la eritropoyesis (AEEs).
English: Sodium phosphate monobasic
Spanish: Fosfato sódico monobásico Fosfato sódico dibásico Cloruro de sodio
English: Aranesp 200 micrograms solution for injection in vial.
Spanish: Aranesp 200 microgramos solución inyectable en vial.
English: Aranesp is supplied ready for use in a pre-filled syringe.
Spanish: Aranesp se presenta listo para su administración en jeringas precargadas.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 60 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 60 µg inyectable
English: Aranesp 200 micrograms solution for injection in vial Each vial contains 200 micrograms of darbepoetin alfa in 1 mL (200 mcg/mL).
Spanish: Aranesp 200 microgramos solución inyectable en vial Cada vial contiene 200 microgramos de darbepoetina alfa en 1 ml (200 µg/ml).
English: NAME OF THE MEDICINAL PRODUCT Aranesp 300 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 300 µg inyectable
English: How to store Aranesp
Spanish: Conservación de Aranesp
English: Aranesp 40 micrograms solution for injection in vial Each vial contains 40 micrograms of darbepoetin alfa in 1 mL (40 mcg/mL).
Spanish: Aranesp 40 microgramos solución inyectable en vial Cada vial contiene 40 microgramos de darbepoetina alfa en 1 ml (40 µg/ml).
English: • Pain around the area injected
Spanish: • Dolor en el lugar de la inyección
English: EU/1/01/185/111 4 pack
Spanish: EU/1/01/185/111 4 envases
English: Do not use this medicine after the expiry date which is stated on the carton and on the vial label after EXP.
Spanish: No utilice este medicamento después de la fecha de caducidad que aparece en la caja y en el vial después de “CAD” o “EXP”.
English: INFORMATION IN BRAILLE Aranesp 30 pen
Spanish: INFORMACIÓN EN BRAILLE Aranesp 30 pluma
English: Aranesp 60 micrograms solution for injection in vial.
Spanish: Aranesp 60 microgramos solución inyectable en vial.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 40 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 40 µg inyectable
English: The initial every other week dose of Aranesp (mcg/every other week) can be determined by dividing the total cumulative dose of r-HuEPO administered over a two-week period by 240.
Spanish: La dosis inicial de Aranesp administrada cada dos semanas (µg/cada dos semanas) puede calcularse dividiendo entre 240 la dosis total acumulada de r-HuEPO administrada durante un periodo de dos semanas.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 25 micrograms solution for injection in vial Darbepoetin alfa
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 25 microgramos solución inyectable en vial Darbepoetina alfa
English: NAME OF THE MEDICINAL PRODUCT Aranesp 80 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 80 µg inyectable
English: Aranesp 40 micrograms solution for injection in vial.
Spanish: Aranesp 40 microgramos solución inyectable en vial.
English: INFORMATION IN BRAILLE Aranesp 150 syringe
Spanish: INFORMACIÓN EN BRAILLE Aranesp 150 jeringa
English: Aranesp 500 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 3.79 mg of sodium in 1 mL.
Spanish: Aranesp 500 microgramos solución inyectable en pluma precargada Cada pluma precargada contiene 3,79 mg de sodio en 1 ml.
English: Aranesp 300 micrograms solution for injection in vial Each vial contains 300 micrograms of darbepoetin alfa in 1 mL (300 mcg/mL).
Spanish: Aranesp 300 microgramos solución inyectable en vial Cada vial contiene 300 microgramos de darbepoetina alfa en 1 ml (300 µg/ml).
English: NAME OF THE MEDICINAL PRODUCT Aranesp 50 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 50 µg inyectable
English: Paediatric chronic renal failure population
Spanish: Insuficiencia renal crónica en población pediátrica
English: If the rise in haemoglobin is greater than 2 g/dL (1.25 mmol/L) in four weeks reduce the dose by approximately 25%.
Spanish: Si el aumento de la hemoglobina es superior a 2 g/dl (1,25 mmol/l) en un periodo de 4 semanas, la dosis se debe reducir aproximadamente un 25%.
English: If the rise in haemoglobin is greater than 2 g/dL (1.25 mmol/L) in four weeks reduce the dose by approximately 25%, depending on the rate of increase.
Spanish: Si el aumento de la hemoglobina es superior a los 2 g/dl (1,25 mmol/l) en cuatro semanas, reducir la dosis aproximadamente un 25%, dependiendo de la velocidad de aumento de la hemoglobina.
English: INFORMATION IN BRAILLE Aranesp 40 syringe
Spanish: INFORMACIÓN EN BRAILLE Aranesp 40 jeringa
English: NAME OF THE MEDICINAL PRODUCT Aranesp 30 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 30 µg inyectable
English: Aranesp 500 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 3.79 mg of sodium in 1 mL.
Spanish: Aranesp 500 microgramos solución inyectable en jeringa precargada Cada jeringa precargada contiene 3,79 mg de sodio en 1 ml.
English: Aranesp 100 micrograms solution for injection in vial Each vial contains 100 micrograms of darbepoetin alfa in 1 mL (100 mcg/mL).
Spanish: Aranesp 100 microgramos solución inyectable en vial Cada vial contiene 100 microgramos de darbepoetina alfa en 1 ml (100 µg/ml).
English: NAME OF THE MEDICINAL PRODUCT Aranesp 100 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 100 µg inyectable
English: Aranesp 15 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 1.42 mg of sodium in 0.375 mL.
Spanish: Aranesp 15 microgramos solución inyectable en jeringa precargada Cada jeringa precargada contiene 1,42 mg de sodio en 0,375 ml.
English: Aranesp 300 micrograms solution for injection in vial.
Spanish: Aranesp 300 microgramos solución inyectable en vial.
English: INFORMATION IN BRAILLE Aranesp 10 syringe
Spanish: INFORMACIÓN EN BRAILLE Aranesp 10 jeringa
English: Aranesp 60 micrograms solution for injection in vial Each vial contains 60 micrograms of darbepoetin alfa in 1 mL (60 mcg/mL).
Spanish: Aranesp 60 microgramos solución inyectable en vial Cada vial contiene 60 microgramos de darbepoetina alfa en 1 ml (60 µg/ml).
English: NAME OF THE MEDICINAL PRODUCT Aranesp 15 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 15 µg inyectable
English: Aranesp 300 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 2.27 mg of sodium in 0.6 mL.
Spanish: Aranesp 300 microgramos solución inyectable en jeringa precargada Cada jeringa precargada contiene 2,27 mg de sodio en 0,6 ml.
English: Aranesp 25 micrograms solution for injection in vial 1 mL solution for injection (25 mcg/mL darbepoetin alfa) in a type 1 glass vial with fluoropolymer laminated elastomeric stopper and an aluminium seal with flip-off dust cover.
Spanish: Aranesp 25 microgramos solución inyectable en vial 1 ml solución inyectable (25 µg/ml darbepoetina alfa) en viales de vidrio tipo 1 con tapón de elastómero laminado fluoropolímero y una cápsula de cierre de aluminio del tipo flip-off.
English: Injection site pain
Spanish: Dolor en el lugar de la inyección
English: INFORMATION IN BRAILLE Aranesp 60 pen
Spanish: INFORMACIÓN EN BRAILLE Aranesp 60 pluma
English: INFORMATION IN BRAILLE Aranesp 80 syringe
Spanish: INFORMACIÓN EN BRAILLE Aranesp 80 jeringa
English: INFORMATION IN BRAILLE Aranesp 20 pen
Spanish: INFORMACIÓN EN BRAILLE Aranesp 20 pluma
English: Aranesp 100 micrograms solution for injection in vial.
Spanish: Aranesp 100 microgramos solución inyectable en vial.
English: Aranesp 15 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 1.42 mg of sodium in 0.375 mL.
Spanish: Aranesp 15 microgramos solución inyectable en pluma precargada Cada pluma precargada contiene 1,42 mg de sodio en 0,375 ml.
English: INFORMATION IN BRAILLE Aranesp 100 pen
Spanish: INFORMACIÓN EN BRAILLE Aranesp 100 pluma
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 1 mL vial contains 25 micrograms darbepoetin alfa.
Spanish: PRINCIPIO(S) ACTIVO(S) Cada vial contiene 25 microgramos de darbepoetina alfa.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 10 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 10 µg inyectable
English: Aranesp 15 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 15 micrograms of darbepoetin alfa in 0.375 mL (40 mcg/mL).
Spanish: Aranesp 15 microgramos solución inyectable en pluma precargada Cada pluma precargada contiene 15 microgramos de darbepoetina alfa en 0,375 ml (40 µg/ml).
English: Treatment with Aranesp should be temporarily discontinued if haemoglobin levels exceed 13 g/dL (8.1 mmol/L).
Spanish: Si los niveles de hemoglobina superan los 13 g/dl (8,1 mmol/l) se debe interrumpir temporalmente el tratamiento con Aranesp.
English: INFORMATION IN BRAILLE Aranesp 150 pen
Spanish: INFORMACIÓN EN BRAILLE Aranesp 150 pluma
English: INFORMATION IN BRAILLE Aranesp 20 syringe
Spanish: INFORMACIÓN EN BRAILLE Aranesp 20 jeringa
English: Aranesp 15 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 15 micrograms of darbepoetin alfa in 0.375 mL (40 mcg/mL).
Spanish: Aranesp 15 microgramos solución inyectable en jeringa precargada Cada jeringa precargada contiene 15 microgramos de darbepoetina alfa en 0,375 ml (40 µg/ml).
English: INFORMATION IN BRAILLE Aranesp 300 syringe
Spanish: INFORMACIÓN EN BRAILLE Aranesp 300 jeringa
English: The initial every other week dose of Aranesp (mcg/every other week) can be determined by dividing the total cumulative dose of r-HuEPO administered over a two-week period by 200.
Spanish: La dosis inicial de Aranesp administrado cada dos semanas (µg/cada dos semanas) puede calcularse dividiendo entre 200 la dosis total acumulada de r-HuEPO administrada durante un periodo de dos semanas.
English: INFORMATION IN BRAILLE Aranesp 15 syringe
Spanish: INFORMACIÓN EN BRAILLE Aranesp 15 jeringa
English: NAME OF THE MEDICINAL PRODUCT Aranesp 500 µg injection
Spanish: NOMBRE DEL MEDICAMENTO Aranesp 500 µg inyectable
English: INFORMATION IN BRAILLE Aranesp 100 syringe
Spanish: INFORMACIÓN EN BRAILLE Aranesp 100 jeringa
English: INFORMATION IN BRAILLE Aranesp 60 syringe
Spanish: INFORMACIÓN EN BRAILLE Aranesp 60 jeringa
English: INFORMATION IN BRAILLE Aranesp 30 syringe
Spanish: INFORMACIÓN EN BRAILLE Aranesp 30 jeringa
English: INFORMATION IN BRAILLE Aranesp 500 pen
Spanish: INFORMACIÓN EN BRAILLE Aranesp 500 pluma
English: Aranesp 130 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 2.46 mg of sodium in 0.65 mL.
Spanish: Aranesp 130 microgramos solución inyectable en jeringa precargada Cada jeringa precargada contiene 2,46 mg de sodio en 0,65 ml.
English: Aranesp 30 micrograms solution for injection pre-filled pen EU/1/01/185/048 - 1 pack
Spanish: Aranesp 30 microgramos solución inyectable en pluma precargada EU/1/01/185/048 envase unitario
English: INFORMATION IN BRAILLE Aranesp 130 pen
Spanish: INFORMACIÓN EN BRAILLE Aranesp 130 pluma
English: PRE-FILLED SYRINGE LABEL WHEN USED WITHOUT TRAY
Spanish: ETIQUETA DE LA JERINGA NO ACONDICIONADA EN BANDEJA
English: INFORMATION IN BRAILLE Aranesp 300 pen
Spanish: INFORMACIÓN EN BRAILLE Aranesp 300 pluma
English: Aranesp 25 micrograms solution for injection in vial Each vial contains 3.79 mg of sodium.
Spanish: Aranesp 25 microgramos solución inyectable en vial Cada vial contiene 3,79 mg de sodio.
English: When your vial has been removed from the refrigerator and left at room temperature for approximately 30 minutes before injection it must either be used within 7 days or disposed of.
Spanish: Una vez que haya sacado el vial de la nevera y la haya dejado a temperatura ambiente durante aproximadamente 30 minutos antes de inyectársela, deberá utilizarla en los 7 días siguientes o desecharla.
English: Aranesp 300 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 2.27 mg of sodium in 0.6 mL.
Spanish: Aranesp 300 microgramos solución inyectable en pluma precargada Cada pluma precargada contiene 2,27 mg de sodio en 0,6 ml.
English: Aranesp 130 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 2.46 mg of sodium in 0.65 mL.
Spanish: Aranesp 130 microgramos solución inyectable en pluma precargada Cada pluma precargada contiene 2,46 mg de sodio en 0,65 ml.
English: Aranesp 150 micrograms solution for injection in pre-filled pen.
Spanish: Aranesp 150 microgramos solución inyectable en pluma precargada.
English: EU/1/01/185/107 4 pack
Spanish: EU/1/01/185/107 4 envases
English: Keep the pre-filled syringe in the outer carton in order to protect from light.
Spanish: Conservar la jeringa precargada dentro del embalaje exterior para protegerlo de la luz.